Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Transplant Proc ; 42(7): 2816-20, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20832596

RESUMEN

Restoring blood flow to ischemic tissue is a prerequisite for treatment of ischemic diseases. Cell-based therapy based on bone marrow transplantation is a promising option for patients with critical limb ischemia (CLI). The efficacy of cell therapies to augment neovascularization seems to involve endothelial progenitor cells (EPCs); however, the mechanisms underlying the efficacy have not been fully elucidated. Herein we have described the case of a young patient with severe CLI, who experienced a 24-month beneficial clinical response to autologous bone marrow transplantation. The exceptional amelioration enabled him to perform standardized maximal treadmill exercise test that demonstrated lack of exercise-induced EPC mobilization, despite adequate stromal-derived factor 1 and vascular endothelial growth factor responses. Therefore, tissue ischemia is not sufficient to promote the recruitment of EPCs that have been demonstrated to be involved in the recovery from ischemia. The local implantation of marrow-derived elements may provide cells and/or trophic factors, which have the capacity to augment angiogenesis, opening new approaches to the etiopathogenesis of the disease.


Asunto(s)
Arteriopatías Oclusivas/complicaciones , Trasplante de Médula Ósea/métodos , Movilización de Célula Madre Hematopoyética/métodos , Isquemia/patología , Pierna/irrigación sanguínea , Adulto , Aorta Abdominal/diagnóstico por imagen , Velocidad del Flujo Sanguíneo , HDL-Colesterol/sangre , Humanos , Hiperemia/diagnóstico por imagen , Hiperemia/fisiopatología , Arteria Ilíaca/diagnóstico por imagen , Isquemia/etiología , Pruebas de Función Renal , Pruebas de Función Hepática , Masculino , Neovascularización Fisiológica , Tomografía Computarizada por Rayos X
2.
Bone Marrow Transplant ; 42(10): 667-72, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18695661

RESUMEN

Long-term effects of autologous mononuclear bone marrow cell transplantation were studied in patients with severe peripheral arterial disease (PAD) and critical limb ischemia. Ten patients with end-stage disease were infused twice with autologous bone marrow cells and they completed the 12-month follow-up study. Substantial improvement of blood flow and increasing capillary densities were seen when compared with a concomitant control group comprising patients who did not enroll in the study. The ankle-brachial index (ABI) and pain-free walking distance improved significantly in treated patients. The improvement was sustained 12 months after treatment. These results confirm that the autologous bone marrow transplantation is an effective therapeutic strategy in critical limb ischemia.


Asunto(s)
Trasplante de Médula Ósea , Enfermedades Vasculares Periféricas/terapia , Adulto , Anciano , Anciano de 80 o más Años , Índice Tobillo Braquial , Velocidad del Flujo Sanguíneo , Femenino , Humanos , Isquemia/terapia , Pierna/patología , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Reoperación , Trasplante Autólogo , Resultado del Tratamiento , Caminata
3.
Curr Microbiol ; 53(5): 374-8, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17048069

RESUMEN

Alpha-galactosidase (alpha-Gal) enzyme, which is encoded by the melA gene hydrolyzes alpha-1,6 galactoside linkages found in sugars, such as raffinose and stachyose. These alpha-galacto-oligosaccharides (alpha-GOS), which are found in large quantities in vegetables, such as soy, can cause gastrointestinal disorders in sensitive individuals because monogastric animals (including humans) do not posses alpha-Gal in the gut. The use of microbial alpha-Gal is a promising alternative to eliminate alpha-GOS in soy-derived products. Using degenerate primers, the melA gene from Lactobacillus (L.) fermentum CRL722 was identified. The complete genomic sequence of melA (2223 bp), and of the genes flanking melA, were obtained using a combination of polymerase chain reaction-based techniques, and showed strong similarities with the alpha-Gal gene of thermophilic microorganisms. The alpha-Gal gene from L. fermentum CRL722 was cloned and the protein purified from cell-free extracts of the native and recombinant strains using various techniques (ion exchange chromatography, salt precipitation, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and ultra-filtration); Its main biochemical properties were determined. The enzyme was active at moderately high temperatures (55 degrees C) and stable at wide ranges of temperatures and pH. The thermostable alpha-Gal from L. fermentum CRL722 could thus be used for technological applications, such as the removal of alpha-GOS found in soy products. The complete melA gene could also be inserted in other micro-organisms, that can survive in the harsh conditions of the gut to degrade alpha-GOS in situ. Both strategies would improve the overall acceptability of soy-derived products by improving their nutritional value.


Asunto(s)
Limosilactobacillus fermentum/enzimología , alfa-Galactosidasa/genética , Estabilidad de Enzimas , Concentración de Iones de Hidrógeno , Oligosacáridos/metabolismo , Temperatura , alfa-Galactosidasa/metabolismo
4.
G Ital Med Lav Ergon ; 27 Suppl 1: 62-7, 2005.
Artículo en Italiano | MEDLINE | ID: mdl-15915657

RESUMEN

The effects of low-dose lead occupational exposure on neurobehavioral functions are still not well defined by international literature. The objective of this study is to assess by psychometric testing the presence of possible neuropsychological impairment in a group of male Italian workers with low blood lead levels in comparison to an adequate non exposed worker group. Given informed consent to take part to the study, all workers were interviewed about their working and clinical history and underwent determination of blood lead levels (PbB). An internationally validated computerized battery of psychometric tests and a standardized paper-and-pencil version of mood self-rating scale and WAIS-R Vocabulary subtest were also administered to the workers. Exposed workers had a geometric mean of PbB significantly higher than non exposed workers, but rather low (16.4 +/- 1.7 microg/dl). The results of psychometric tests were not significantly different between the two worker groups, even after adjusting for the main confounding factors. In workers exposed to low lead doses no neurobehavioral abnormalities were demonstrated by the administered psychometric test battery.


Asunto(s)
Conducta/efectos de los fármacos , Plomo/farmacología , Sistema Nervioso/efectos de los fármacos , Exposición Profesional/efectos adversos , Adulto , Humanos , Plomo/sangre , Masculino , Persona de Mediana Edad , Pruebas Psicológicas
5.
J Appl Microbiol ; 97(4): 876-81, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15357738

RESUMEN

AIMS: Consumption of soya-derived products has been hampered by the presence of alpha-galactooligosaccharides (alpha-GOS) because mammals lack pancreatic alpha-galactosidase (alpha-Gal) which is necessary for their hydrolysis. These sugars thus reach the large intestine causing gastrointestinal disorders in sensitive individuals. The use of lactic acid bacteria (LAB) expressing alpha-Gal is a promising solution for the degradation of alpha-GOS in soyamilk. METHODS AND RESULTS: The capacity of the LAB Lactobacillus fermentum CRL 722 to properly degrade alpha-GOS was studied in vitro using controlled fermentation conditions and in vivo using a rat model. Lactobacillus fermentum CRL 722 was able to grow on commercial soyamilk and completely eliminated stachyose and raffinose during fermentation because of its high alpha-Gal activity. Rats fed soyamilk fermented by this LAB had smaller caecums compared with rats fed unfermented soyamilk. CONCLUSIONS: Soyamilk fermentation by Lact. fermentum CRL 722 results in the reduction of alpha-GOS concentrations in soyamilk, thus eliminating possible undesirable physiological effects normally associated with its consumption. SIGNIFICANCE AND IMPACT OF THE STUDY: Fermentation with Lact. fermentum CRL 722 could prevent gastrointestinal disorders in sensitive individuals normally associated with the consumption of soya-based products. This LAB could thus be used in the elaboration of novel fermented vegetable products which better suit the digestive capacities of consumers.


Asunto(s)
Microbiología de Alimentos , Galactosa/metabolismo , Lactobacillus/metabolismo , Oligosacáridos/metabolismo , Leche de Soja , Animales , Ciego/anatomía & histología , Ciego/metabolismo , Recuento de Colonia Microbiana/métodos , Fermentación , Lactobacillus/crecimiento & desarrollo , Rafinosa/metabolismo , Ratas , Ratas Wistar , alfa-Galactosidasa/metabolismo
6.
Genet. mol. res. (Online) ; 3(3): 432-440, 2004. ilus, graf
Artículo en Inglés | LILACS | ID: lil-482166

RESUMEN

Human consumption of soy-derived products has been limited by the presence of non-digestible oligosaccharides (NDO), such as the alpha-galactooligosaccharides raffinose and stachyose. Most mammals, including man, lack pancreatic alpha-galactosidase (alpha-Gal), which is necessary for the hydrolysis of these sugars. However, such NDO can be fermented by gas-producing microorganisms present in the cecum and large intestine, which in turn can induce flatulence and other gastrointestinal disorders in sensitive individuals.The use of microorganisms expressing alpha-Gal is a promising solution to the elimination of NDO before they reach the large intestine. In the present study, lactic acid bacteria engineered to degrade NDO have been constructed and are being used as a tool to evaluate this solution. The alpha-Gal structural genes from Lactobacillus plantarum ATCC8014 (previously characterized in our laboratory) and from guar have been cloned and expressed in Lactococcus lactis. The gene products were directed to different bacterial compartments to optimize their possible applications. The alpha-Gal-producing strains are being evaluated for their efficiency in degrading raffinose and stachyose: i) in soymilk fermentation when used as starters and ii) in situ in the upper gastrointestinal tract when administered to animals orally, as probiotic preparations. The expected outcomes and possible complications of this project are discussed.


Asunto(s)
Animales , Digestión , Lactobacillus plantarum/metabolismo , Lactococcus lactis/metabolismo , Leche de Soja/química , Oligosacáridos/metabolismo , Rafinosa/metabolismo , alfa-Galactosidasa/genética , Productos Lácteos Cultivados , Fermentación , Alimentos Modificados Genéticamente , Lactobacillus plantarum/crecimiento & desarrollo , Lactococcus lactis/crecimiento & desarrollo , Probióticos , Roedores , alfa-Galactosidasa/metabolismo
7.
G Ital Med Lav Ergon ; 25 Suppl(3): 114-5, 2003.
Artículo en Italiano | MEDLINE | ID: mdl-14979109

RESUMEN

The aim of this study is to evaluate the effects of occupational exposure to low inorganic lead (Pb) doses on blood pressure of exposed (E) workers. 44 workers of a foundry of lead wrecks and 14 workers employed in enameling and decoration of a manufacturing firm of artistic ceramics were examined. The group of non-exposed (NE) subjects is formed by 59 workers of packaging unit of a food industry. A questionnaire has been administered to all the workers on general characteristics and life habits. Systolic and diastolic blood pressure were also measured and venous blood collection performed for the determination of blood lead levels. Mean blood lead levels (PbB) and mean diastolic blood pressure (DBP) resulted significantly higher in the group of exposed workers of the foundry. Stratifing exposed workers with respect to the median of PbB (18 micrograms/dl), workers with PbB > 18 micrograms/dl presented a mean DBP significantly higher than exposed with PbB < or = 18 micrograms/dl and non-exposed subjects. PbB takes part significantly in determination of DBP, also considering main confounding factors as age, BMI, pack-years and alcohol consumption.


Asunto(s)
Presión Sanguínea/efectos de los fármacos , Plomo/toxicidad , Exposición Profesional/efectos adversos , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA